Literature DB >> 22329556

Missing data in substance abuse treatment research: current methods and modern approaches.

Sterling McPherson1, Celestina Barbosa-Leiker, G Leonard Burns, Donelle Howell, John Roll.   

Abstract

Two common procedures for the treatment of missing information, listwise deletion and positive urine analysis (UA) imputation (e.g., if the participant fails to provide urine for analysis, then score the UA positive), may result in significant biases during the interpretation of treatment effects. To compare these approaches and to offer a possible alternative, these two procedures were compared to the multiple imputation (MI) procedure with publicly available data from a recent clinical trial. Listwise deletion, single imputation (i.e., positive UA imputation), and MI missing data procedures were used to comparatively examine the effect of two different buprenorphine/naloxone tapering schedules (7- or 28-days) for opioid addiction on the likelihood of a positive UA (Clinical Trial Network 0003; Ling et al., 2009). The listwise deletion of missing data resulted in a nonsignificant effect for the taper while the positive UA imputation procedure resulted in a significant effect, replicating the original findings by Ling et al. (2009). Although the MI procedure also resulted in a significant effect, the effect size was meaningfully smaller and the standard errors meaningfully larger when compared to the positive UA procedure. This study demonstrates that the researcher can obtain markedly different results depending on how the missing data are handled. Missing data theory suggests that listwise deletion and single imputation procedures should not be used to account for missing information, and that MI has advantages with respect to internal and external validity when the assumption of missing at random can be reasonably supported.

Entities:  

Mesh:

Year:  2012        PMID: 22329556      PMCID: PMC3785093          DOI: 10.1037/a0027146

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  12 in total

1.  A comparison of inclusive and restrictive strategies in modern missing data procedures.

Authors:  L M Collins; J L Schafer; C M Kam
Journal:  Psychol Methods       Date:  2001-12

2.  Missing data: our view of the state of the art.

Authors:  Joseph L Schafer; John W Graham
Journal:  Psychol Methods       Date:  2002-06

3.  Last observation carry-forward and last observation analysis.

Authors:  Jun Shao; Bob Zhong
Journal:  Stat Med       Date:  2003-08-15       Impact factor: 2.373

4.  Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation.

Authors:  Richard J Cook; Leilei Zeng; Grace Y Yi
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

5.  Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.

Authors:  Xiaowei Yang; Steven Shoptaw
Journal:  Drug Alcohol Depend       Date:  2005-03-07       Impact factor: 4.492

Review 6.  A primer on the use of modern missing-data methods in psychosomatic medicine research.

Authors:  Craig K Enders
Journal:  Psychosom Med       Date:  2006 May-Jun       Impact factor: 4.312

7.  How many imputations are really needed? Some practical clarifications of multiple imputation theory.

Authors:  John W Graham; Allison E Olchowski; Tamika D Gilreath
Journal:  Prev Sci       Date:  2007-06-05

Review 8.  Missing data analysis: making it work in the real world.

Authors:  John W Graham
Journal:  Annu Rev Psychol       Date:  2009       Impact factor: 24.137

9.  Stereotyping and the treatment of missing data for drug and alcohol clinical trials.

Authors:  Stephan Arndt
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-02-18

10.  A comparison of missing data methods for hypothesis tests of the treatment effect in substance abuse clinical trials: a Monte-Carlo simulation study.

Authors:  Sarra L Hedden; Robert F Woolson; Robert J Malcolm
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-06-03
View more
  31 in total

1.  The Relationship Between Suicide Ideation, Behavioral Health, and College Academic Performance.

Authors:  Susan M De Luca; Cynthia Franklin; Yan Yueqi; Shannon Johnson; Chris Brownson
Journal:  Community Ment Health J       Date:  2016-01-29

2.  Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003.

Authors:  Celestina Barbosa-Leiker; Sterling McPherson; Mary Rose Mamey; G Leonard Burns; Matthew E Layton; John Roll; Walter Ling
Journal:  Drug Alcohol Depend       Date:  2015-04-11       Impact factor: 4.492

3.  Parallel modeling of pain and depression in prediction of relapse during buprenorphine and naloxone treatment: A finite mixture model.

Authors:  Noel A Vest; Sterling McPherson; G Leonard Burns; Sarah Tragesser
Journal:  Drug Alcohol Depend       Date:  2020-02-26       Impact factor: 4.492

4.  A randomized clinical trial of motivational interviewing plus skills training vs. Relaxation plus education and 12-Steps for substance using incarcerated youth: Effects on alcohol, marijuana and crimes of aggression.

Authors:  L A R Stein; Rosemarie Martin; Mary Clair-Michaud; Rebecca Lebeau; Warren Hurlbut; Christopher W Kahler; Peter M Monti; Damaris Rohsenow
Journal:  Drug Alcohol Depend       Date:  2019-12-13       Impact factor: 4.492

Review 5.  Longitudinal missing data strategies for substance use clinical trials using generalized estimating equations: an example with a buprenorphine trial.

Authors:  Sterling McPherson; Celestina Barbosa-Leiker; Michael McDonell; Donelle Howell; John Roll
Journal:  Hum Psychopharmacol       Date:  2013-09       Impact factor: 1.672

6.  Contingency management targeting abstinence is effective in reducing depressive and anxiety symptoms among crack cocaine-dependent individuals.

Authors:  André Q C Miguel; Clarice S Madruga; Hugo Cogo-Moreira; Rodolfo Yamauchi; Viviane Simões; Ariadne Ribeiro; Claudio J da Silva; Andrew Fruci; Michael McDonell; Sterling McPherson; John M Roll; Ronaldo R Laranjeira
Journal:  Exp Clin Psychopharmacol       Date:  2017-12       Impact factor: 3.157

7.  A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual.

Authors:  Joy M Schmitz; Angela L Stotts; Anka A Vujanovic; Michael F Weaver; Jin H Yoon; Jessica Vincent; Charles E Green
Journal:  Contemp Clin Trials       Date:  2017-12-26       Impact factor: 2.226

8.  Predictors of tobacco and alcohol co-use from ages 15 to 32: The Amsterdam Growth and Health Longitudinal Study.

Authors:  Sterling M McPherson; Ekaterina Burduli; Crystal Lederhos Smith; Olivia Brooks; Michael F Orr; Celestina Barbosa-Leiker; Trynke Hoekstra; Michael G McDonell; Sean M Murphy; Matthew Layton; John M Roll
Journal:  Exp Clin Psychopharmacol       Date:  2018-08-27       Impact factor: 3.157

9.  Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy.

Authors:  Jeremiah W Bertz; David H Epstein; David Reamer; William J Kowalczyk; Karran A Phillips; Ashley P Kennedy; Michelle L Jobes; Greg Ward; Barbara A Plitnick; Mariana G Figueiro; Mark S Rea; Kenzie L Preston
Journal:  J Subst Abuse Treat       Date:  2019-08-14

10.  A 'missing not at random' (MNAR) and 'missing at random' (MAR) growth model comparison with a buprenorphine/naloxone clinical trial.

Authors:  Sterling McPherson; Celestina Barbosa-Leiker; Mary Rose Mamey; Michael McDonell; Craig K Enders; John Roll
Journal:  Addiction       Date:  2014-10-16       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.